[HTML][HTML] COVID and the kidney: an update
Summary Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2, has led to a global pandemic that continues to be responsible for …
syndrome coronavirus 2, has led to a global pandemic that continues to be responsible for …
What has vaccination against COVID-19 in CKD patients taught us?
M Rossi, G Pessolano, G Gambaro - Journal of Nephrology, 2023 - Springer
Effective vaccination strategies are of crucial importance to protecting patients who are
vulnerable to infections, such as patients with chronic kidney disease. This is because the …
vulnerable to infections, such as patients with chronic kidney disease. This is because the …
Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: study protocol for a randomised, controlled trial of immunosuppression …
Kidney transplant recipients are at an increased risk of severe COVID-19-associated
hospitalisation and death. Vaccination has been a key public health strategy to reduce …
hospitalisation and death. Vaccination has been a key public health strategy to reduce …
Measures to Increase Immunogenicity of SARS-CoV-2 Vaccines in Solid Organ Transplant Recipients: A Narrative Review
Purpose of review: To review the data on the immunogenicity of COVID-19 vaccines,
administered by different strategies, in solid organ transplant recipients (SOTRs). Recent …
administered by different strategies, in solid organ transplant recipients (SOTRs). Recent …
Dietary Inulin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients: The RIVASTIM-Inulin Randomised Controlled Trial
Kidney transplant recipients are at an increased risk of hospitalisation and death from SARS-
CoV-2 infection, and standard two-dose vaccination schedules are typically inadequate to …
CoV-2 infection, and standard two-dose vaccination schedules are typically inadequate to …
Benefits of inactivated vaccine and viral vector vaccine immunization on COVID-19 infection in kidney transplant recipients
N Sutharattanapong, S Thotsiri, S Kantachuvesiri… - Vaccines, 2022 - mdpi.com
The coronavirus virus disease 2019 (COVID-19) pandemic has impacted the global
healthcare system. In Thailand, the first and most available vaccines were inactivated and …
healthcare system. In Thailand, the first and most available vaccines were inactivated and …
SARS‐CoV‐2 seropositivity in renal transplant patients administered intravenous immunoglobulin.
BZ Sim, BL Sim, MJ Tunbridge… - Transplant …, 2023 - search.ebscohost.com
SARS-CoV-2 seropositivity in renal transplant patients administered intravenous
immunoglobulin Patient 1 had negative anti-NC (0.0608 COI) and anti-RBD IgG (< 0.4 …
immunoglobulin Patient 1 had negative anti-NC (0.0608 COI) and anti-RBD IgG (< 0.4 …
Immune profiling of COVID-19 vaccine responses in people with multiple sclerosis on B cell-depleting therapy
ABSTRACT Background and Objective People with multiple sclerosis (pwMS) receiving B
cell-depleting therapies have impaired antibody responses to vaccination. In a proportion of …
cell-depleting therapies have impaired antibody responses to vaccination. In a proportion of …
Clinical implications of COVID-19 in chronic kidney disease and end-stage kidney disease
P Cockwell, MD Griffin - Understanding the Pandemic, 2025 - Elsevier
Patients with chronic kidney disease (CKD), particularly those receiving dialysis or with a
kidney transplant, are among the highest risk groups from SARS-CoV-2 infection. For …
kidney transplant, are among the highest risk groups from SARS-CoV-2 infection. For …
mTOR inhibition improves the formation of functional T cell memory following COVID-19 vaccination of kidney transplant recipients
Inadequate immune response to vaccination is a long-standing problem faced by
immunosuppressed kidney transplant recipients (KTRs), requiring novel strategies to …
immunosuppressed kidney transplant recipients (KTRs), requiring novel strategies to …